Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,518 | 94,857 | 113,024 | 65,582 | 112,666 |
| Marketable Securities | 759,703 | 981,157 | 501,800 | 716,995 | 358,972 |
| Receivables | 17,764 | 16,650 | 1,283 | 147 | 51,819 |
| TOTAL | $916,975 | $1,107,940 | $628,051 | $795,186 | $535,672 |
| Non-Current Assets | |||||
| PPE Net | 79,194 | 65,815 | 68,748 | 80,453 | 73,271 |
| Investments And Advances | 335,048 | 145,055 | 40,534 | 46,708 | 152,050 |
| Other Non-Current Assets | 93,320 | 82,863 | 86,983 | 92,428 | 80,326 |
| TOTAL | $507,562 | $293,733 | $196,265 | $219,589 | $305,647 |
| Total Assets | $1,424,537 | $1,401,673 | $824,316 | $1,014,775 | $841,319 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 41,181 | 11,520 | 10,080 | 958 | N/A |
| Accounts payable and accrued liabilities | 22,337 | 20,369 | 21,507 | 25,611 | 21,087 |
| Accrued Expenses | 83,278 | 55,323 | 42,641 | 44,096 | 34,370 |
| Other current liabilities | 34,933 | 21,114 | 10,559 | 1,123 | 1,540 |
| TOTAL | $202,452 | $179,674 | $102,678 | $84,617 | $71,860 |
| Non-Current Liabilities | |||||
| Long Term Debt | 246,384 | 93,227 | 58,384 | 63,810 | 47,367 |
| Deferred Revenues | 1,612 | 52,370 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,635,326 | 1,264,144 | 1,049,577 | 974,248 | 391,229 |
| TOTAL | $1,881,710 | $1,357,371 | $1,107,961 | $1,038,058 | $525,596 |
| Total Liabilities | $2,084,162 | $1,537,045 | $1,210,639 | $1,122,675 | $597,456 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 123,163 | 118,411 | 103,005 | 95,161 | 84,856 |
| Common Shares | 123 | 118 | 102 | 94 | 84 |
| Retained earnings | -3,486,719 | -2,701,764 | -2,112,238 | -1,585,994 | -1,207,620 |
| Other shareholders' equity | 630 | 2,398 | -10 | -3,590 | -869 |
| TOTAL | $-659,625 | $-135,372 | $-386,323 | $-107,900 | $243,863 |
| Total Liabilities And Equity | $1,424,537 | $1,401,673 | $824,316 | $1,014,775 | $841,319 |